Kamada Ltd. (KMDA) News Nov 20, 2014, 4:00

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Kamada Ltd. (KMDA) News Nov 20, 2014, 4:00 p.m.
MarketWatch News on KMDA
No News currently available for KMDA

Other News on KMDA
3 Stocks Pushing The Drugs Industry Lower 3:32 p.m. Nov. 13, 2014 - TheStreet.com
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 7:12 a.m. Oct. 3, 2014 - Seeking Alpha
Kamada extends Glassia supply agreement 12:56 p.m. Sept. 29, 2014 - Seeking Alpha
Investors Should Exercise Caution With REVO Biologics IPO 7:22 a.m. Sept. 16, 2014 - Seeking Alpha
Silver Spring Networks Starts The Week Strong 12:30 p.m. Sept. 8, 2014 - TheStreet.com
Kamada Plunges Following Missed Marks In Trial 11:52 a.m. Sept. 4, 2014 - TheStreet.com
Kamada AATD therapeutic fails in clinical trial 6:35 a.m. Sept. 4, 2014 - Seeking Alpha
Kamada updates revenue guidance after Q2 results 9:02 a.m. Aug. 14, 2014 - Seeking Alpha
Should You Get Rid of Kamada (KMDA) Now? - Tale of the Tape 7:34 a.m. July 11, 2014 - Zacks.com
Weekly 3-Year Low Highlights: FMS, SNOW, KMDA, LAYN 4:55 p.m. June 16, 2014 - GuruFocus.com
Should You Get Rid of Kamada (KMDA) Now? - Tale of the Tape 7:53 a.m. May 20, 2014 - Zacks.com
Kamada reports mixed results in AAT trial 6:42 a.m. May 16, 2014 - Seeking Alpha
Kamada Enters Oversold Territory (KMDA) 10:59 a.m. May 8, 2014 - TheStreet.com
Omni Bio Raises Cash, Wastes No Time Getting Back To Work 10:14 a.m. May 2, 2014 - Seeking Alpha
Why You Need to Pay Attention to Kamada (KMDA) Stock? - Tale of the Tape 9:00 a.m. March 7, 2014 - Zacks.com
Six Israeli Biotech New Issues Set A Blistering Pace 5:12 p.m. Jan. 14, 2014 - Investors Business Daily
Biotech Investor Realism With Andrew Fein 12:36 p.m. Sept. 4, 2013 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 9:45 a.m. Aug. 7, 2013 - InvestorPlace.com
Kamada's CEO Discusses Q2 2013 Results - Earnings Call Transcript 6:16 p.m. Aug. 2, 2013 - Seeking Alpha
Press Releases on KMDA
Kamada Announces Third Quarter 2014 Financial Results 7:03 a.m. Nov. 12, 2014 - BusinessWire - BZX
Kamada to Host Third Quarter 2014 Financial Results Conference Call on November 12, 2014 7:01 a.m. Nov. 10, 2014 - BusinessWire - BZX
FDA Grants Kamada Orphan Drug Designation for the Treatment of Graft versus Host Disease 7:36 a.m. Oct. 29, 2014 - BusinessWire - BZX
Kamada Announces Study in Support of Alpha-1 Antitrypsin for the Treatment of Type-1 Diabetes Published in the Journal of Diabetes Science and Technology 6:00 a.m. Oct. 21, 2014 - BusinessWire - BZX
Kamada Announces Second Extension of Strategic Agreement with Baxter 5:30 a.m. Sept. 29, 2014 - BusinessWire - BZX
Kamada to Announce Final Results from Phase 2/3 Clinical TrialofInhaled AAT to Treat Alpha-1 Antitrypsin Deficiency on September 4, 2014 3:29 p.m. Sept. 3, 2014 - BusinessWire - BZX
Kamada Reports Second Quarter Financial Results 7:03 a.m. Aug. 14, 2014 - BusinessWire - BZX
Kamada to Host Second Quarter Financial Results Conference Call on Thursday, August 14, 2014 6:00 a.m. Aug. 6, 2014 - BusinessWire - BZX
Kamada Announces Preliminary Results from Phase II/III Pivotal Trial in Europe and Canada of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency 6:31 a.m. May 16, 2014 - BusinessWire - BZX
Kamada to Announce Results from Phase 2/3 Clinical TrialofInhaled AAT to Treat Alpha-1 Antitrypsin Deficiency on May 16 12:31 a.m. May 15, 2014 - BusinessWire - BZX
Kamada Reports First Quarter Financial Results 6:41 a.m. May 8, 2014 - BusinessWire - BZX
Kamada Announces Significantly Improved Infusion Rate for Glassia® 7:05 a.m. April 24, 2014 - BusinessWire - BZX
Kamada Announces U.S. Proof-of-Concept Study with Glassia® for Graft-Versus-Host Disease 6:01 a.m. April 3, 2014 - BusinessWire - BZX
Kamada Announces Initiation of a Phase 2 U.S. Clinical Trial of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency 6:01 a.m. March 24, 2014 - BusinessWire - BZX
Outbrain Appoints Ziv Kop As COO 12:30 p.m. March 21, 2014 - PR Newswire - PRF
Kamada to Report Top-Line Data from Phase 2/3 Clinical Trial of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency by Late April or Early May 6:01 a.m. March 21, 2014 - BusinessWire - BZX
Kamada Initiates Phase 2/3 Clinical Trial of Glassia to Treat Newly Diagnosed Pediatric Patients with Type 1 Diabetes 7:01 a.m. March 5, 2014 - BusinessWire - BZX
Kamada Completes Enrollment in U.S. Pivotal Clinical Trial with KamRAB as a Post-Exposure Treatment for Rabies 8:04 a.m. March 4, 2014 - BusinessWire - BZX
Kamada Ltd. [KMDA] to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Feb. 24, 2014 - GlobeNewswire
Kamada to Ring The NASDAQ Stock Market Opening Bell on February 25, 2014 8:31 a.m. Feb. 24, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intellectia.AI Transforming Trading with AI Upgrades

Updated Category News Views 2

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Continue Reading
Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Updated Category News Views 3

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Continue Reading
Celebree Elevates Early Ed with New Certification Push

Updated Category News Views 3

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...

Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel

Updated Category News Views 5

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Continue Reading
Goodwill's ReThink Fashion: Textiles to Runway Art

Updated Category News Views 3

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

Continue Reading
Innventure Faces Major Lawsuit Amidst Market Turmoil

Updated Category News Views 0

The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...

Continue Reading
How Timekettle Is Bridging Language Gaps at IFA 2026

Updated Category News Views 4

Pioneering AI Innovations in Language Translation Timekettle is making some serious waves at IFA 2026, throwing its hat in the ring with innovations that redefine multilingual interaction. From sleek translation earbuds to full-blown meeting hubs, each gadget screams one thing loud and clear—communication sans language barriers. Centered in the tech extravaganza of...

Continue Reading
Jollibee and DreamWorks Unite for Cultural Celebration

Updated Category News Views 4

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Continue Reading
IDX Expands, Enhances Team Amid 56% H1 Growth

Updated Category News Views 1

IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...

Continue Reading
Austin PostalAnnex Changes Hands After 19 Years

Updated Category News Views 3

A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Updates for PepGen Inc. Investors Ahead of Class Action

Updated Category News Views 210

Key Information for PepGen Inc. Investors As a valued member of the investment community, it is crucial to stay informed about developments regarding PepGen Inc. (NASDAQ: PEPG). Recently, investors have been alerted about a class action lawsuit, and it is vital to understand its implications as well as how investors like you can respond effectively. Understanding the...

Continue Reading
Ginkgo Bioworks and Google Cloud Revolutionize Drug Development

Updated Category News Views 92

Unlocking the Future of Drug Development In a bold step towards transforming the pharmaceutical industry, Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) has rolled out two groundbreaking tools aimed at speeding up the drug development process. This initiative has been made possible through a strengthened partnership with Google Cloud, a subsidiary of Alphabet Inc. The focus...

Continue Reading
Investing in Growth: The Vanguard Mega Cap Growth ETF Opportunity

Updated Category News Views 204

The S&P 500 isn’t just a bunch of random stocks; it’s home to about 500 companies where the heavyweights like Apple, Nvidia, and Microsoft play a huge role. Back then, these tech titans held a jaw-dropping market cap of around $9.8 trillion—yeah, that's about 19.7% of the entire S&P 500! You could practically feel the desks humming with excitement as Nvidia...

Continue Reading
O-I Glass Insights: Strong Q1 Performance and 2025 Outlook

Updated Category News Views 230

O-I Glass Reports Impressive First Quarter Results PERRYSBURG, Ohio — O-I Glass, Inc. (NYSE: OI) delivered robust financial results for the first quarter, showcasing a strong start to 2025. Underpinning this performance is the company's 'Fit to Win' strategy, which aims to enhance competitiveness and profitability. Key Financial Highlights O-I Glass reported structural...

Continue Reading
Sharp Imaging Celebrates Winning Three Prestigious Frank Awards

Updated Category News Views 274

Sharp Imaging Triumphs at the Frank Awards Sharp Imaging and Information Company of America, a division of Sharp Electronics Corporation, has demonstrated remarkable resilience and excellence by winning three prestigious Frank Awards at The Cannata Report's 40th Annual Awards & Charities Gala. This event took place at a renowned venue and marks the eighth consecutive year...

Continue Reading